6 withdrawn. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Withdrawn 6 |
Follow Epilepsy: new trials by email Literature Review of Epilepsy trials Research Report on Epilepsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of Cognitive Outcomes With Cannabidiol Oral Solution GWP42003-P - Lennox-Gastaut Syndrome | Phase 4 | Withdrawn | Jazz Pharmaceuticals | 2020-10-01 | 2022-09-01 | |
| Anxiety and Depression in Epilepsy: A Pilot Treatment Study Escitalopram 10mg - Anxiety, Depression | Phase 4 | Withdrawn | Wake Forest University Health Sciences | 2018-05-01 | 2019-09-12 | |
| To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures Perampanel, Placebo - Epilepsy, Partial | Phase 4 | Withdrawn | Eisai Inc. | 2015-03-01 | 2015-02-10 | |
| An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms Vigabatrin - Infantile Spasms | Phase 4 | Withdrawn | Lundbeck LLC | 2012-06-01 | 2012-09-13 | |
| Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects melatonin, placebo - Lennox-Gastaut Syndrome | Phase 4 | Withdrawn | Institution de Lavigny | 2011-08-01 | 2022-07-14 | |
| Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline Pregabalin-Lyrica, Sertraline - Epilepsy, Anxiety | Phase 4 | Withdrawn | Rush University Medical Center | 2009-11-01 | 2023-02-02 |
Anxiety Disorders (2) · Lennox Gastaut Syndrome (2) · Sleep Initiation and Maintenance Disorders (2) · Depression (1) · Epilepsies, Partial (1) · Nervous System Diseases (1) · Seizures (1) · Spasms, Infantile (1)
Brain Diseases (6) · Central Nervous System Diseases (6) · Nervous System Diseases (5) · Mental Disorders (4) · Epileptic Syndromes (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Dyssomnias (2) · Genetic Diseases, Inborn (2) · Sleep Disorders, Intrinsic (2) · Sleep Wake Disorders (2) · Behavior (1) · Behavioral Symptoms (1) · Epilepsy, Generalized (1) · Neurologic Manifestations (1)
Cannabidiol (1) · Escitalopram (1) · Melatonin (1) · Pregabalin (1) · Sertraline (1) · Vigabatrin (1) · perampanel (1)
Eisai Inc. (1) · Institution de Lavigny (1) · Jazz Pharmaceuticals (1) · Lundbeck LLC (1) · Rush University Medical Center (1) · Wake Forest University Health Sciences (1)
United States (2) · Switzerland (1)
Andre M. Kanner, MD (1) · Giovanni B. Foletti, MD, MER (1) · Heidi Munger Clary, MD (1)
5UL1TR001420-03 (1)